Lupin Q3 profit plunges 72% to Rs 153 crore due to high base, revenue grows 4%
Lupin filed 7 ANDAs (abbreviated new drug applications) during the quarter, received 2 ANDA approvals from the US FDA, and launched 4 products in the US. The company now has 166 generic products in the US.
Latest News from Moneycontrol.com